Should serum calcitonin be routinely measured in patients with thyroid nodules--will the law answer before endocrinologists do?

Comment

L J Deftos. J Clin Endocrinol Metab. 2004 Sep.

. 2004 Sep;89(9):4768-9; author reply 4769-70.

doi: 10.1210/jc.2004-0314.

No abstract available

Comment on

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.
Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A, Pacini F. Elisei R, et al. J Clin Endocrinol Metab. 2004 Jan;89(1):163-8. doi: 10.1210/jc.2003-030550. J Clin Endocrinol Metab. 2004. PMID: 14715844
The calcitonin conundrum--is it time for routine measurement of serum calcitonin in patients with thyroid nodules?
Hodak SP, Burman KD. Hodak SP, et al. J Clin Endocrinol Metab. 2004 Feb;89(2):511-4. doi: 10.1210/jc.2003-031983. J Clin Endocrinol Metab. 2004. PMID: 14764754 Review. No abstract available.